Join to View Full Profile
113 University PlSte 1019New York, NY 10003
Dr. Sporn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Harvard Medical SchoolResidency, Psychiatry, 1995 - 1999
Tufts Medical CenterResidency, Psychiatry, 1984 - 1988
University of Miami Leonard M. Miller School of MedicineClass of 1984
Certifications & Licensure
NY State Medical License 2008 - 2027
FL State Medical License 1995 - 2018
MD State Medical License 2000 - 2003
American Board of Psychiatry and Neurology Psychiatry
Publications & Presentations
PubMed
- 2 citationsGM-1020: a novel, orally bioavailable NMDA receptor antagonist with rapid and robust antidepressant-like effects at well-tolerated doses in rodents.Adam K Klein, Eric W Austin, Michael J Cunningham, Dino Dvorak, Silvia Gatti
Neuropsychopharmacology. 2024-05-01 - 6 citationsRapid tolerance to behavioral effects of ethanol in rats: prevention by R-(-)-ketamine.Hana Shafique, Jeffrey M. Witkin, Jodi L. Smith, Kyle Kaniecki, Jonathan Sporn
Pharmacology, Biochemistry, and Behavior. 2021-04-01
Press Mentions
ATAI Life Sciences Acquires Majority Stake in Perception Neuroscience to Develop Arketamine Therapy for Neuropsychiatric DiseasesJanuary 3rd, 2019
ATAI Life Sciences Acquires Majority Stake in Perception Neuroscience to Develop Arketamine Therapy for Neuropsychiatric DiseasesJanuary 3rd, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
